Institutional
Nan Fung Group Holdings Ltd
CIK 0001782539
$121.3M
Reported AUM
24
Positions
Q1 2026
Period
2026-05-14
Filed
The Brief · Nan Fung Group Holdings Ltd · Q1 2026
AI · grounded in 13F
Nan Fung Group Holdings Ltd established a new position in CELC valued at $3.23M. The fund also opened a new position in INSM for $1.08M and increased its stake in LBRX by 110.22%. On the sell side, the fund closed its position in LAB, reducing its exposure by $2.41M.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EVMN | EVOMMUNE INC | $19.92 | -3.72% | 8.20% | 16.36% | $33.1M | 27.32% | — | HELD |
| 2 | MPLT | MAPLIGHT THERAPEUTICS INC | $28.01 | -6.94% | 65.54% | 105.50% | $19.7M | 16.28% | — | HELD |
| 3 | LBRX | LB PHARMACEUTICALS INC | $28.53 | -1.28% | 69.82% | 76.88% | $15.6M | 12.82% | +330,657 | +110.2% |
| 4 | OCS | OCULIS HOLDING AG | $11.21 | -5.24% | -43.72% | 16.05% | $9.3M | 7.69% | −163,957 | −31.9% |
| 5 | INCY | INCYTE CORP | $102.38 | 1.13% | 48.87% | 32.36% | $5.1M | 4.17% | −5,280 | −8.9% |
| 6 | ONC | BEONE MEDICINES LTD | $270.10 | -3.51% | 5.57% | -14.68% | $4.7M | 3.85% | — | HELD |
| 7 | RYTM | RHYTHM PHARMACEUTICALS INC | $86.40 | -1.38% | 26.85% | 399.71% | $4.3M | 3.52% | — | HELD |
| 8 | CELC | CELCUITY INC | $88.28 | -4.53% | 576.48% | 348.12% | $3.2M | 2.66% | +28,300 | NEW |
| 9 | ASNDUSD | ASCENDIS PHARMA A/S | — | — | — | — | $3.1M | 2.57% | — | HELD |
| 10 | PCOR | PROCORE TECHNOLOGIES INC | $48.57 | -4.20% | -28.43% | -52.97% | $3.0M | 2.51% | — | HELD |
| 11 | MDGL | MADRIGAL PHARMACEUTICALS INC | $486.98 | -1.19% | 75.03% | 457.70% | $3.0M | 2.45% | −6,200 | −52.2% |
| 12 | KYMR | KYMERA THERAPEUTICS INC | $74.13 | -0.64% | 55.67% | 23.18% | $2.6M | 2.12% | — | HELD |
| 13 | ACAD | ACADIA PHARMACEUTICALS INC | $21.56 | -0.74% | -1.91% | -0.32% | $2.3M | 1.89% | — | HELD |
| 14 | HELP | CYBIN INC | $4.15 | -6.32% | -53.37% | -96.42% | $2.2M | 1.82% | — | HELD |
| 15 | ARGX | ARGENX SE | $891.32 | 5.82% | 52.12% | 192.78% | $2.0M | 1.69% | — | HELD |
| 16 | RVMD | REVOLUTION MEDICINES INC | $149.23 | -4.15% | 263.18% | 421.05% | $1.9M | 1.54% | — | HELD |
| 17 | RXRX | RECURSION PHARMACEUTICALS IN | $3.32 | -12.76% | -39.62% | -89.08% | $1.8M | 1.51% | — | HELD |
| 18 | INSM | INSMED INC | $94.22 | -10.20% | 27.98% | 283.01% | $1.1M | 0.89% | +6,580 | NEW |
| 19 | ETHA | ISHARES ETHEREUM TR | $11.87 | -11.35% | -36.90% | -37.56% | $800K | 0.66% | — | HELD |
| 20 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $32.20 | -2.31% | -9.55% | 23.09% | $758K | 0.62% | — | HELD |
| 21 | TRDA | ENTRADA THERAPEUTICS INC | $6.37 | -9.00% | -23.44% | -78.61% | $619K | 0.51% | — | HELD |
| 22 | IBIT | ISHARES BITCOIN TRUST ETF | $34.14 | -5.22% | -42.39% | -3.61% | $613K | 0.51% | — | HELD |
| 23 | RANI | RANI THERAPEUTICS HLDGS INC | $0.83 | -7.68% | 48.13% | -95.50% | $363K | 0.30% | — | HELD |
| 24 | BOLT | BOLT BIOTHERAPEUTICS INC | $4.56 | -4.20% | -29.41% | -97.96% | $118K | 0.10% | −29,097 | −49.9% |
| 25 | LAB | STANDARD BIOTOOLS INC | $1.15 | -9.45% | 8.49% | -84.48% | — | — | −1,883,179 | EXITED |
| 26 | REPL | REPLIMUNE GROUP INC | $9.47 | -4.05% | -8.77% | -71.07% | — | — | −63,719 | EXITED |
| 27 | BCYC | BICYCLE THERAPEUTICS PLC | $4.20 | -1.64% | -50.88% | -86.71% | — | — | −68,943 | EXITED |
| 28 | RKLB | ROCKET LAB CORP | $110.08 | -8.23% | 280.64% | 982.40% | — | — | −3,824 | EXITED |
| 29 | BSLK | BOLT PROJS HLDGS INC | $0.07 | 0.00% | -97.50% | -99.96% | — | — | −40,597 | EXITED |
Source: SEC EDGAR · accession 0001012975-26-000423. 13F discloses long positions only — shorts, foreign equities, and options are excluded.